Highlights and Quick Summary
- Capex per Share for the quarter ending December 31, 2022 was -0.0 (a -95.77% decrease compared to previous quarter)
- Year-over-year quarterly Capex per Share decreased by -95.83%
- Annual Capex per Share for 2022 was -0.02 (a 0.93% increase from previous year)
- Annual Capex per Share for 2021 was -0.02 (a 245.16% increase from previous year)
- Annual Capex per Share for 2020 was -0.01 (a -97.43% decrease from previous year)
- Twelve month Capex per Share ending December 31, 2022 was -0.02 (a -34.15% decrease compared to previous quarter)
- Twelve month trailing Capex per Share decreased by -34.74% year-over-year
Trailing Capex per Share for the last four month:
| 31 Dec '22 | 30 Sep '22 | 30 Jun '22 | 31 Mar '22 |
|---|---|---|---|
| -0.02 | -0.03 | -0.04 | -0.03 |
Visit stockrow.com/PGEN
for comprehensive keystats, realtime prices, income statement, balance sheet, cash flow
statement with 10 years of data, and state-of-the-art screener.
Historical Capex per Share of Precigen, Inc.
Most recent Capex per Shareof PGEN including historical data for past 10 years.Interactive Chart of Capex per Share of Precigen, Inc.
Precigen, Inc. Capex per Share for the past 10 Years (both Annual and Quarterly)
| Year | Q1 | Q2 | Q3 | Q4 | Fiscal Year |
|---|---|---|---|---|---|
| 2022 | -0.0 | -0.01 | -0.01 | -0.01 | -0.02 |
| 2021 | -0.01 | -0.01 | -0.0 | 0.0 | -0.02 |
| 2020 | 0.02 | -0.0 | -0.01 | -0.02 | -0.01 |
| 2019 | -0.03 | -0.05 | -0.09 | -0.07 | -0.24 |
| 2018 | -0.08 | -0.06 | -0.08 | -0.08 | -0.3 |
| 2017 | -0.11 | -0.12 | -0.09 | -0.05 | -0.38 |
| 2016 | -0.1 | -0.09 | -0.05 | -0.04 | -0.27 |
| 2015 | -0.02 | -0.03 | -0.04 | -0.02 | -0.11 |
| 2014 | -0.01 | -0.01 | -0.01 | -0.03 | -0.06 |
| 2013 | -0.01 | 0.0 | -0.11 | -0.03 | -0.03 |
| 2012 | 0.0 | -0.03 | -1.27 | – | -1.35 |
Business Profile of Precigen, Inc.
Sector: Healthcare
Industry: Biotechnology